Relationship between the Genetic Polymorphisms of Phase I and II Drug-metabolizing Enzymes, as well as the Outcome of Chemotherapy in Advanced Non-small Cell Lung Cancer

Relationship between the Genetic Polymorphisms of Phase I and II Drug-metabolizing Enzymes, as well as the Outcome of Chemotherapy in Advanced Non-small Cell Lung Cancer

Background and objective Currently available studies on the polymorphisms of drug-metabolizing enzymes and their chemotherapeutic effects in non-small cell lung cancer are not consistent. In the present study, the relationship of the gene polymorphisms of cytochrome P450 1A1 (CYP1A1), cytochrome P45...

Full description

Bibliographic Details
Main Authors: Weiying LI, Wentao YUE, Xuehui YANG, Chunyan ZHANG, Yue WANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2011-11-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Drugs metabolism enzymes
Chemotherapy response
Prognosis
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2011.11.05

Similar Items

Similar Items